| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 08/02/2007 | WO2005084329A3 Method for inhibiting tumor formation and growth |
| 08/02/2007 | WO2005037858A3 Template-directed assembly of receptor signaling complexes |
| 08/02/2007 | WO2004091519A3 Methods of preventing or treating respiratory conditions |
| 08/02/2007 | US20070180545 TAT-031 and methods of assessing and treating cancer |
| 08/02/2007 | US20070180543 Non-steroidal anti-inflammatory drug activated gene with anti-tumorigenic properties |
| 08/02/2007 | US20070179192 Thrombopoietin mimetics |
| 08/02/2007 | US20070179179 respiratory diseases such as asthma, chronic obstructive pulmonary disease, bronchitis; useful in the treatment of nervous system injury and premature labor; 1-{2-[N-2-(4-hydroxy-3-formylaminophenyl)-2-(RS) hydroxyethyl]aminoethyl}-4-[N-(2-phenyl-2-(RS)-hydroxyethyl)amino]phenyl; milveterol |
| 08/02/2007 | US20070179103 Immunostimulatory oligonucleotide multimers |
| 08/02/2007 | US20070179101 biodrug as antitumor agent, a vaccine adjuvant for infections and cancers, and antiallergy agents |
| 08/02/2007 | US20070179087 Method for treating inflammatory diseases using heat shock proteins |
| 08/02/2007 | US20070178563 Mosaic infectious bursal disease virus vaccines |
| 08/02/2007 | US20070178562 Consensus/ancestral immunogens |
| 08/02/2007 | US20070178555 Attenuated rabies virus with nucleoprotein mutation at the phosphorylation site for vaccination against rabies and gene therapy in the CNS |
| 08/02/2007 | US20070178540 Goodpasture antigen binding protein |
| 08/02/2007 | US20070178438 Apolipoprotein c-1 induced apoptosis |
| 08/02/2007 | US20070178122 Fusion proteins comprising modified allergens of the ns-ltps family, use thereof and pharmaceutical compositions comprising the same |
| 08/02/2007 | US20070178121 Methods for enhancing skin treatments |
| 08/02/2007 | US20070178120 Virus-like particles as vaccines for paramyxovirus |
| 08/02/2007 | US20070178119 Veterinary medicine; brain disorders; immunizing with vaccine comprising West Nile virus or plasmid DNA, an adjuvant such as a metabolizable oil carrier |
| 08/02/2007 | US20070178117 chimeric protein comprises epitopes of the loop 5 region and/or the alpha helix 5 region of outer surface protein C (OspC) types associated with mammalian Borrelia infections; vaccine and diagnostic for Lyme disease |
| 08/02/2007 | US20070178116 Group B streptococcus polypeptides nucleic acids and therapeutic compositions and vaccines thereof |
| 08/02/2007 | US20070178115 Immunization of avians by administration of non-replicating vectored vaccines |
| 08/02/2007 | US20070178114 Novel kallikrein gene |
| 08/02/2007 | US20070178113 Superantigen conjugate |
| 08/02/2007 | US20070178112 Immunoglobulins; immunogens |
| 08/02/2007 | US20070178111 Identification and application of antibiotic synergy |
| 08/02/2007 | US20070178110 Surface-located campylobacter jejuni polypeptides |
| 08/02/2007 | US20070178109 glycoprotein 120; fusion proteins; myelin basic protein; autoimmune diseases; genetic vaccines |
| 08/02/2007 | US20070178108 Colon Specific Gene and Protein and Cancer |
| 08/02/2007 | US20070178107 Method and means for treating solid tumors |
| 08/02/2007 | US20070178106 Compositions and methods for enhancing nk cell activity |
| 08/02/2007 | US20070178105 FHIT proteins and nucleic acids and methods based thereon |
| 08/02/2007 | US20070178104 Methods and means for treating solid tumors |
| 08/02/2007 | US20070178103 CD19-specific immunotoxin and treatment method |
| 08/02/2007 | US20070178102 Methods of identifying combinations of antibodies with an improved anti-tumor activity and compositions and methods using the antibodies |
| 08/02/2007 | US20070178101 Ovr110 antibody compositions and methods of use |
| 08/02/2007 | US20070178100 genetically engineered T. cruzi wherein the amastigote stage-regulated protein is expressed from a gene involved in energy metabolism; suitable for use in diagnosis of Chagas disease, in drug development, in antibody production, and in the production of vaccines, including live vaccines |
| 08/02/2007 | US20070178099 Suppression of TNFalpha and IL-12 in therapy |
| 08/02/2007 | US20070178098 Interleukin-6 antagonists |
| 08/02/2007 | US20070178097 Interleukin-10 antibodies |
| 08/02/2007 | US20070178096 producing an antibody by inoculating an animal with a polypeptide; monoclonal antibody specifically binds to a zalpha11 polypeptide; treating blood disorders |
| 08/02/2007 | US20070178095 Anti-myostatin antibodies |
| 08/02/2007 | US20070178094 Autoimmune diseases; antitumor agents; antiallergens; enhancing the immune response of an individual to a specific molecule, by enhancing the MHC class II presentation of an antigenic epitope of the molecule to T lymphocytes of the individual |
| 08/02/2007 | US20070178093 Lymphocytes; methods |
| 08/02/2007 | US20070178092 Humanized anti-CD3 specific antibodies |
| 08/02/2007 | US20070178091 Combination Therapy |
| 08/02/2007 | US20070178090 Breast endothelial cell expression patterns |
| 08/02/2007 | US20070178089 Mucosal vascular addressins and uses thereof |
| 08/02/2007 | US20070178088 Fibronectins; drug screening; treating cardiovascular/nervous system disorders |
| 08/02/2007 | US20070178087 Method for Treating Immune Dysfunction by Regulation of CD40 Ligand Expression |
| 08/02/2007 | US20070178086 Monoclonal antibody against ABCA1 |
| 08/02/2007 | US20070178085 BoNT/A Peptides and Methods of Predicting and Reducing Immunoresistance to Botulinum Toxin Therapy |
| 08/02/2007 | US20070178084 Continuous flow chamber device for separation, concentration, and/or purfication of cells |
| 08/02/2007 | US20070178083 Medicinal compositions containing Fc receptor gamma-chain activator |
| 08/02/2007 | US20070178082 Stabilized single domain antibodies |
| 08/02/2007 | US20070178072 Method for inducing differentiation of regulatory t cells usinggip-anchored protein agonist and pharmaceutical composition therefor ( as amended |
| 08/02/2007 | US20070178065 Neutralizing factors as vaccine adjuvants |
| 08/02/2007 | US20070178063 Methods of treating cancer using il-21 and monoclonal antibody therapy |
| 08/02/2007 | US20070178044 Methods for Detecting DNA Damage and Screening for Cancer Therapeutics |
| 08/02/2007 | DE102006003782A1 Treatment and prevention of autoimmune diseases, e.g. hemolytic anemia or arteriosclerosis, by extracorporeal adsorption of autoantibodies on to specific autoantigens |
| 08/02/2007 | DE10138935B4 Synthetische Verbindungen vom Nicht-Mucintyp oder ihre mit einem Träger konjugierten Verbindungen, unter deren Verwendung hergestellte monoclonale Antikörper, diese umfassende Antitumormittel Immunstimulantien und Mittel gegen das humane Immundefizienzvirus Synthetic compounds from non-mucin or its conjugated with a carrier compounds monoclonal antibody prepared using them, this comprehensive antitumor agents and immunostimulants agents against human immunodeficiency virus |
| 08/02/2007 | CA2640248A1 Influenza vaccines containing hemagglutinin and matrix proteins |
| 08/02/2007 | CA2640087A1 Methods and compositions for modulating the mobilization of stem cells |
| 08/02/2007 | CA2638905A1 Methods and compositions of targeted drug development |
| 08/02/2007 | CA2637929A1 Anti-fcrn antibodies for treatement of auto/allo immune conditions |
| 08/02/2007 | CA2637917A1 Therapeutic agents for diseases involving choroidal neovascularization |
| 08/02/2007 | CA2637690A1 Tumour vaccine comprising allogeneic or xenogeneic tumour cells |
| 08/02/2007 | CA2637463A1 Synergistic compositions for treating hiv |
| 08/02/2007 | CA2637156A1 Methods for modulating mannose content of recombinant proteins |
| 08/02/2007 | CA2636867A1 Vaccines and immunotherapeutics using codon optimized il-15 and methods for using the same |
| 08/02/2007 | CA2636854A1 Ligands that bind il-4 and/or il-13 |
| 08/02/2007 | CA2635208A1 Streptococcus pneumonia having a capsular polysaccharide repeating unit (>2) glucose 1(1>3) glucose 2(1>3) rhamnose (1>3) ribitol (5>phosphate) |
| 08/02/2007 | CA2634888A1 Novel glycolipid adjuvant compositions |
| 08/02/2007 | CA2622312A1 Combination therapy for the treatment of neovascular disorders |
| 08/02/2007 | CA2535127A1 H3 equine influenza a virus |
| 08/01/2007 | EP1813681A2 Use of the slug gene or the replication, transcription or expression products thereof in the identification, diagnosis, prevention or treatment of the spread of cancer and/or the development of metastasis |
| 08/01/2007 | EP1813626A1 Antigen-binding fragments specific for dendritic cells, compositions and methods of use thereof, antigens recognized thereby and cells obtained thereby |
| 08/01/2007 | EP1812797A2 Compositions and methods for the treatment and prevention of hyperproliferative diseases |
| 08/01/2007 | EP1812794A2 Autocrine growth factor receptors and methods |
| 08/01/2007 | EP1812597A2 Mammalian genes involved in infection |
| 08/01/2007 | EP1812580A2 Multivalent vaccines comprising recombinant viral vectors |
| 08/01/2007 | EP1812573A1 Mutant porcine reproductive and respiratory syndrome virus |
| 08/01/2007 | EP1812564A2 Defective influenza virus particles |
| 08/01/2007 | EP1812563A2 Methods of generating antigen-specific cd4+cd25+ regulatory t cells, compositions and methods of use |
| 08/01/2007 | EP1812475A2 Immunoglobulin fractions |
| 08/01/2007 | EP1812077A2 Modulators of epha2 and ephrina1 for the treatment of fibrosis-related disease |
| 08/01/2007 | EP1812068A2 Methods of preventing and treating rsv infections and related conditions |
| 08/01/2007 | EP1812067A1 Compositions against sars-coronavirus and uses thereof |
| 08/01/2007 | EP1812066A2 Staphylococcus aureus isd protein-based anti-infectives |
| 08/01/2007 | EP1812065A2 High affinity antibodies against hmgb1 and methods of use thereof |
| 08/01/2007 | EP1812064A2 Use of vascular endothelial growth factor receptor 1+ cells in treating and monitoring cancer and in screening for chemotherapeutics |
| 08/01/2007 | EP1812063A2 Monoclonal antibodies to the propeptide of candida albicans and methods of use |
| 08/01/2007 | EP1812061A2 Treatment and prevention of hypersensitivity and/or anaphylaxis with anti-ige antibodies in patients receiving replacement therapy |
| 08/01/2007 | EP1812059A2 Method of preventive treatment of allergy by mucosal administration of an allergy vaccine |
| 08/01/2007 | EP1812058A2 Chlamydia trachomatis antigens for vaccine and diagnostic use |
| 08/01/2007 | EP1812057A2 Modified streptococcal polysaccharides and uses thereof |
| 08/01/2007 | EP1812056A2 Immunogenic compositions containing anthrax antigen, biodegradable polymer microparticles, and polynucleotide-containing immunological adjuvant |
| 08/01/2007 | EP1812055A1 Chlamydia antigens and uses thereof |
| 08/01/2007 | EP1812054A2 Methods and compositions for immunizing against pseudomonas infection |
| 08/01/2007 | EP1812053A1 Iontophoretic device and method for administering immune response-enhancing agents and compositions |